Inhibrx Biosciences, Inc. stays a Strong Buy with Q2 2026 ozekibart BLA catalyst, 2026 PFS data, and Ewing sarcoma updates.
Community Resource Center (CRC) is now accepting nominations for the inaugural 2026 CRC Community Impact Awards, honoring individuals, youth, groups or organizations who demonstrate exceptional ...
Mock voting is a preparatory process in which control units are connected to ballot units and two test votes are cast on each ballot unit ...
That'll a be a huge, 50-storey, fully-carpeted yep according to YouTuber DocJade. He decided that installing and running the ...
BBO-8520 monotherapy in patients with KRASG12C non-small cell lung cancer (NSCLC) showed a 65% objective response rate (ORR) ...
The analyses of progression-free survival (PFS) and overall survival (OS) remain on track for late Q1 2026 in the ongoing Phase 2/3 COMPANION-002 ...
A tropical low has now formed in the Coral Sea, prompting warnings of heavy rainfall and damaging winds along more than a ...
Incyte Corporation rated Buy on surging Hem/Onc growth, Monjuvi/Minjuvi catalysts, frontMIND data and strong cash. Click for ...
First patient dosed in Phase 2 ASPEN-09-Breast trial evaluating evorpacept in combination with trastuzumab and physician’s ...
Generation Z, millennials and Generation X are more likely to get colorectal cancer – but funding cuts could see the search for a cure grind to a halt.
The UN Child Rights Committee (CRC) will sessions from 12 – 30 January, during which it will review the files of seven countries ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback